Wyeth, Cordis Stent Patents Are Invalid, Judge Says
A New Jersey federal judge on Thursday ruled that two stent patents by Cordis Corp. and Pfizer Inc. unit Wyeth Pharmaceuticals Inc. are invalid in a suit accusing Abbott Laboratories, Boston...To view the full article, register now.
Already a subscriber? Click here to view full article